NEOK-001

N/A

Report date: 2026/05/09 20:00:18

First In Class

Base Information

Drug NameNEOK-001

Drug Alias NameNEOK001NEOK-001ABL206ABL-206

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payload

Mechanisms of ActionAnti-CD276Anti-Inactive tyrosine-protein kinase transmembrane receptor ROR1DNA topoisomerase I inhibitors

TargetsCD276 antigenInactive tyrosine-protein kinase transmembrane receptor ROR1DNA topoisomerase I

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAbl Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesNEOK Bio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A